Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds' ability to cause secondary leukemias after treatment?

This publication has 23 references indexed in Scilit:

• Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers
  European Journal Of Cancer, 1996
• The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals
  Mutagenesis, 1995
• Mechanism of action of DNA topoisomerase inhibitors
  The International Journal of Cell Cloning, 1995
• Mutagenicity and carcinogenicity of topoisomerase-interactive agents
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
• Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias
  Annals of Hematology, 1994
• Topoisomerase II enzymes and mutagenicity
  Environmental and Molecular Mutagenesis, 1994
• Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation
  Mutation Research/Genetic Toxicology, 1993
• The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
• Therapy-Related Acute Myelogenous Leukemia Associated with 11q23 Chromosomal Abnormalities and Topoisomerase II Inhibitors: Report of Four Additional Cases and Brief Commentary
  Leukemia & Lymphoma, 1993
• Apoptosis induced by anticancer drugs
  Cancer and Metastasis Reviews, 1992